Home > Publications database > Hematopoietic stem and progenitor cell-restricted Cdx2 expression induces transformation to myelodysplasia and acute leukemia. > print

001     156883
005     20240229123119.0
024 7 _ |a 10.1038/s41467-020-16840-2
|2 doi
024 7 _ |a pmid:32541670
|2 pmid
024 7 _ |a pmc:PMC7296000
|2 pmc
024 7 _ |a altmetric:84038377
|2 altmetric
037 _ _ |a DKFZ-2020-01190
041 _ _ |a eng
082 _ _ |a 500
100 1 _ |a Vu, Therese
|0 0000-0003-2831-2957
|b 0
245 _ _ |a Hematopoietic stem and progenitor cell-restricted Cdx2 expression induces transformation to myelodysplasia and acute leukemia.
260 _ _ |a [London]
|c 2020
|b Nature Publishing Group UK
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1594193054_23026
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a The caudal-related homeobox transcription factor CDX2 is expressed in leukemic cells but not during normal blood formation. Retroviral overexpression of Cdx2 induces AML in mice, however the developmental stage at which CDX2 exerts its effect is unknown. We developed a conditionally inducible Cdx2 mouse model to determine the effects of in vivo, inducible Cdx2 expression in hematopoietic stem and progenitor cells (HSPCs). Cdx2-transgenic mice develop myelodysplastic syndrome with progression to acute leukemia associated with acquisition of additional driver mutations. Cdx2-expressing HSPCs demonstrate enrichment of hematopoietic-specific enhancers associated with pro-differentiation transcription factors. Furthermore, treatment of Cdx2 AML with azacitidine decreases leukemic burden. Extended scheduling of low-dose azacitidine shows greater efficacy in comparison to intermittent higher-dose azacitidine, linked to more specific epigenetic modulation. Conditional Cdx2 expression in HSPCs is an inducible model of de novo leukemic transformation and can be used to optimize treatment in high-risk AML.
536 _ _ |a 312 - Functional and structural genomics (POF3-312)
|0 G:(DE-HGF)POF3-312
|c POF3-312
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Straube, Jasmin
|0 0000-0002-1748-0659
|b 1
700 1 _ |a Porter, Amy H
|b 2
700 1 _ |a Bywater, Megan
|b 3
700 1 _ |a Song, Axia
|b 4
700 1 _ |a Ling, Victoria
|0 0000-0001-9757-1229
|b 5
700 1 _ |a Cooper, Leanne
|b 6
700 1 _ |a Pali, Gabor
|b 7
700 1 _ |a Bruedigam, Claudia
|b 8
700 1 _ |a Jacquelin, Sebastien
|0 0000-0001-5087-3641
|b 9
700 1 _ |a Green, Joanne
|b 10
700 1 _ |a Magor, Graham
|b 11
700 1 _ |a Perkins, Andrew
|0 0000-0003-3644-7093
|b 12
700 1 _ |a Chalk, Alistair M
|0 0000-0002-9630-6236
|b 13
700 1 _ |a Walkley, Carl R
|0 0000-0002-4784-9031
|b 14
700 1 _ |a Heidel, Florian H
|b 15
700 1 _ |a Mukhopadhyay, Pamela
|b 16
700 1 _ |a Cloonan, Nicole
|b 17
700 1 _ |a Gröschel, Stefan
|0 P:(DE-He78)5120a331b1c28045c8ca6a8b1c73c95f
|b 18
|u dkfz
700 1 _ |a Mallm, Jan-Philipp
|0 P:(DE-He78)697cb039ca08f3b7e5a2a52dbf020b46
|b 19
|u dkfz
700 1 _ |a Fröhling, Stefan
|0 P:(DE-He78)f0144d171d26dbedb67c9db1df35629d
|b 20
|u dkfz
700 1 _ |a Scholl, Claudia
|0 P:(DE-He78)2c1a21d1cf5fdc9e297512c9d1354250
|b 21
|u dkfz
700 1 _ |a Lane, Steven W
|0 0000-0002-8050-6209
|b 22
773 _ _ |a 10.1038/s41467-020-16840-2
|g Vol. 11, no. 1, p. 3021
|0 PERI:(DE-600)2553671-0
|n 1
|p 3021
|t Nature Communications
|v 11
|y 2020
|x 2041-1723
909 C O |o oai:inrepo02.dkfz.de:156883
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 18
|6 P:(DE-He78)5120a331b1c28045c8ca6a8b1c73c95f
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 19
|6 P:(DE-He78)697cb039ca08f3b7e5a2a52dbf020b46
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 20
|6 P:(DE-He78)f0144d171d26dbedb67c9db1df35629d
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 21
|6 P:(DE-He78)2c1a21d1cf5fdc9e297512c9d1354250
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-312
|2 G:(DE-HGF)POF3-300
|v Functional and structural genomics
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2020
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NAT COMMUN : 2018
|d 2020-01-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2020-01-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2020-01-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
|d 2020-01-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2020-01-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2020-01-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2020-01-16
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Peer review
|d 2020-01-16
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
|d 2020-01-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2020-01-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1060
|2 StatID
|b Current Contents - Agriculture, Biology and Environmental Sciences
|d 2020-01-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1040
|2 StatID
|b Zoological Record
|d 2020-01-16
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
|d 2020-01-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2020-01-16
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
|d 2020-01-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2020-01-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2020-01-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2020-01-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1150
|2 StatID
|b Current Contents - Physical, Chemical and Earth Sciences
|d 2020-01-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2020-01-16
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b NAT COMMUN : 2018
|d 2020-01-16
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|f 2020-01-16
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2020-01-16
920 1 _ |0 I:(DE-He78)A380-20160331
|k A380
|l Molekulare Leukämogenese
|x 0
920 1 _ |0 I:(DE-He78)B066-20160331
|k B066
|l B066 Chromatin-Netzwerke
|x 1
920 1 _ |0 I:(DE-He78)W192-20160331
|k W192
|l W192 scOpen Lab
|x 2
920 1 _ |0 I:(DE-He78)B340-20160331
|k B340
|l Translationale Medizinische Onkologie
|x 3
920 1 _ |0 I:(DE-He78)B290-20160331
|k B290
|l Angewandte Funktionelle Genomik
|x 4
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)A380-20160331
980 _ _ |a I:(DE-He78)B066-20160331
980 _ _ |a I:(DE-He78)W192-20160331
980 _ _ |a I:(DE-He78)B340-20160331
980 _ _ |a I:(DE-He78)B290-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21